Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Competitive Analysis of the Binding Affinity of Montelukast, Zafirlukast and Gemilukast to CysLTR1, P2Y12 and PPAR-γ and their Possible Cardioprotective Effect: Using in silico Methods

    Matrika Saha Roy1★, Bidduth Kumar Sarkar2, Md Rohan Nadvi1, Arghya Prosun Sarkar3, Sukalyan Kumar Kundu1, Hossain Ahmed2, Md Jahirul Islam2, Barno Kumar Sarkar4, Peter Singh5, Tanushree Maitra6, Maruf Hasan1★ Corresponding author

    1. 1Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, BANGLADESH.
    2. 2Department of Pharmacy, Comilla University, Cumilla, BANGLADESH.
    3. 3Department of Pharmacy, Islamic University, Kushtia, BANGLADESH.
    4. 4Department of Orthopedics, Faridpur Medical College, Faridpur, BANGLADESH.
    5. 5Department of Pharmacy, BRAC University, Dhaka, BANGLADESH.
    6. 6Department of Physiology, Z. H. Sikder Women’s Medical College & Hospital, Dhaka, Bangladesh.

    CORRESPONDENCE

    Matrika Saha Roy

    Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, BANGLADESH.

    roy.stu2013@juniv.edu

    Received: 22-11-2023; Accepted: 17-01-2024.

    Volume 15, Issue 1 · pp. 28–37 · PUBLISHED 2024 · DOI: 10.1177/0976500X241232235

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Background: Asthma is a very common respiratory disorder, affecting more than 360 million people worldwide. It is a chronic inflammatory disorder of the airways with the symptoms of shortness of breath, coughing, chest tightness, wheezing, and sometimes chest pain. Leukotrienes play an important role in bronchoconstriction during the allergen or exercise-induced acute asthma attack. Aim: The study aims to predict the interactions between leukotriene antagonist drugs and CysLT receptor-1 (CysLTR1), P2Y12 and peroxisome proliferator-activated receptor gamma (PPAR-γ) on a competitive basis. The study also has the objective of understanding the cardioprotective roles of the drugs. Introduction: Asthma is strongly linked to the development of acute coronary syndrome by the leukotriene-induced activation of CysLTR1, platelet aggregation and thrombosis by activating P2Y12. PPAR-γ is considered to show benefits against atherosclerosis, diabetes, hypertension, obesity and dyslipidaemia, which are risk factors for the development of cardiovascular disorders. Leukotriene receptor inhibitors act with these three types of receptors to show therapeutic effects. Materials and Methods: To predict the possible interactions between the drugs and the receptors, the study has used in silico methods. Results and Discussion: Montelukast, Zafirlukast and Gemilukast are potential antagonists of CysLTR1 and P2Y12. They are also responsible for the upregulation of PPAR-γ. Thus, these drugs show a cardioprotective role in asthma-induced cardiac disorders. Conclusion: A competitive in silico study of Montelukast, Zafirlukast and Gemilukast to predict their binding to CysLTR1, P2Y12 & PPAR-γ revealed that Montelukast is more effective than the other two drugs for showing a cardioprotective role.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Roy, M. S., Sarkar, B. K., Nadvi, M. R., Sarkar, A. P., Kundu, S. K., Ahmed, H., Islam, M. J., Sarkar, B. K., Singh, P., Maitra, T., & Hasan, M. (2024). Competitive Analysis of the Binding Affinity of Montelukast, Zafirlukast and Gemilukast to CysLTR1, P2Y12 and PPAR-γ and their Possible Cardioprotective Effect: Using in silico Methods. Journal of Pharmacology and Pharmacotherapeutics, 15(1), 28–37. https://doi.org/10.1177/0976500X241232235